Werewolf Therapeutics Inc (HOWL)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $47.64M
Last updated: Nov 17, 2026 at 11:05 AM ET
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 0.7% above its 50-day moving average, and the 50-day average is above the 200-day average. The 14-day RSI is 49.3, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about HOWL
News
HOWL Valuation
HOWL Profitability: Margins, ROIC and FCF
Werewolf Therapeutics (HOWL) has an operating margin of -121.8% and a net margin of -164.8%. It posts a -114.1% FCF margin.
- Operating margin
- -121.8%
- Net margin
- -164.8%
- ROE
- -119.9%
- FCF margin
- -114.1%
Werewolf Therapeutics Competitors
The companies most similar to Werewolf Therapeutics (HOWL) include Elicio Therapeutics, Plus Therapeutics and Oncolytics Biotech.
Sector: Healthcare
Companies most similar to Werewolf TherapeuticsHOWL Bull Case vs Bear Case
Bull case
- HOWL beat EPS estimates in 75.0% of its last 8 reported quarters.
Bear case
- HOWL has a -164.8% net profit margin.
- HOWL's quarterly revenue changed -100.0% year over year.
HOWL Earnings: Beat Rate and Next Report
Werewolf Therapeutics (HOWL) beat the EPS estimate in 6 of the last 8 quarters (75.0%). Its next report is expected on Mar 22, 2027.
- Beat rate
- 6 of 8 quarters (75.0%)
- Average surprise
- 23.6%
- EPS estimate (fiscal period ending Dec 31, 2026)
- -$0.17
HOWL Earnings Date
HOWL reports Mar 22, 2027. The date is estimated.
HOWL ETF Holders
GNG tracks 3 ETFs that hold HOWL. The largest weights:
- Vanguard Morningstar Total Stock Market ETF (VTI), <0.01% of the fund
- Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
- Vanguard Extended Market Index Fund ETF Shares (VXF), <0.01% of the fund
Updated Nov 13, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About HOWL
When does HOWL report earnings?
Werewolf Therapeutics Inc (HOWL) is expected to report earnings on Mar 22, 2027.
Does HOWL pay dividends?
Werewolf Therapeutics Inc (HOWL) does not currently pay a regular dividend.
What is HOWL's market cap?
Werewolf Therapeutics Inc (HOWL) has a market capitalization of $47.64M with a current stock price of $0.99.
HOWL pages: Overview, Earnings, Forecast, Financials, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.